BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37790931)

  • 21. Targeting β3-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway.
    Deng J; Jiang P; Yang T; Huang M; Qi W; Zhou T; Yang Z; Zou Y; Gao G; Yang X
    Biochem Biophys Res Commun; 2019 Jun; 514(1):295-300. PubMed ID: 31030945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
    Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
    J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
    Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
    J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma.
    Gheytanchi E; Mehrazma M; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(7):3065-70. PubMed ID: 24815448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the developmental origin of neuroblastoma: an overview.
    Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
    J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.
    He WG; Yan Y; Tang W; Cai R; Ren G
    Oncotarget; 2017 Jun; 8(23):37730-37739. PubMed ID: 28465480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.
    Dong R; Yang R; Zhan Y; Lai HD; Ye CJ; Yao XY; Luo WQ; Cheng XM; Miao JJ; Wang JF; Liu BH; Liu XQ; Xie LL; Li Y; Zhang M; Chen L; Song WC; Qian W; Gao WQ; Tang YH; Shen CY; Jiang W; Chen G; Yao W; Dong KR; Xiao XM; Zheng S; Li K; Wang J
    Cancer Cell; 2020 Nov; 38(5):716-733.e6. PubMed ID: 32946775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 3-Protein Expression Signature of Neuroblastoma for Outcome Prediction.
    Xie Y; Xu H; Fang F; Li Z; Zhou H; Pan J; Guo W; Zhu X; Wang J; Wu Y
    Am J Surg Pathol; 2018 Aug; 42(8):1027-1035. PubMed ID: 29794872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
    Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
    Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways.
    Avitabile M; Bonfiglio F; Aievola V; Cantalupo S; Maiorino T; Lasorsa VA; Domenicotti C; Marengo B; Zbyněk H; Vojtěch A; Iolascon A; Capasso M
    Comput Struct Biotechnol J; 2022; 20():4437-4445. PubMed ID: 36051886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
    Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
    BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
    Yco LP; Geerts D; Koster J; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
    Li Z; Takenobu H; Setyawati AN; Akita N; Haruta M; Satoh S; Shinno Y; Chikaraishi K; Mukae K; Akter J; Sugino RP; Nakazawa A; Nakagawara A; Aburatani H; Ohira M; Kamijo T
    Oncogene; 2018 May; 37(20):2714-2727. PubMed ID: 29507419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.